Abstract Recent evidence suggests that some human cancers may harbor low-biomass microbial ecosystems, spanning bacteria, viruses, and fungi. Bacteria, the most-studied kingdom in this context, are suggested by these studies to localize within cancer cells, immune cells and other tumor microenvironment cell types, where they are postulated to impact multiple cancer-related functions. Herein, we provide […]
Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45. CAS PubMed Google Scholar Van Leersum N, Janssen-Heijnen M, Wouters M, Rutten H, Coebergh JW, Tollenaar R, Lemmens V. Increasing prevalence of comorbidity in patients with colorectal cancer in […]
Abstract Proton therapy is of great interest to pediatric cancer patients because of its optimal depth dose distribution. In view of healthy tissue damage and the increased risk of secondary cancers, we investigated DNA damage induction and repair of radiosensitive hematopoietic stem and progenitor cells (HSPCs) exposed to therapeutic proton and photon irradiation due to […]
New York, USA, Oct. 09, 2023 (GLOBE NEWSWIRE) — Hemophilia A Market to Exhibit Growth at a Remarkable CAGR During the Study Period (2019-2032) | DelveInsight The current therapeutic landscape of hemophilia A in the United States is driven by several approved therapies. The hemophilia A market is estimated to grow for the period 2019–2032. […]
image: Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer view more Credit: 2023 Bhamidipati and Subbiah. “Several ongoing trials hope to further elucidate the role of lurbinectedin in highgrade neuroendocrine neoplasms […]” BUFFALO, NY- October 6, 2023 – A new editorial paper was published in Oncoscience (Volume 10) on […]
